Angewandte Chemie · 2015 · 18 citations · 23 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryMolecular NeuroscienceTargeted Drug DeliveryBlood-brain Barrier DeliveryBrain Targeted DeliveryLiposomal FormulationsLiposome-based DeliveryNanocarriers For TherapeuticsNeurotransmitter ReceptorsBrain Targeting LigandsLigand StabilityLiposomal Delivery SystemsLiposomal NanocarriersLiposome Delivery SystemsPeptide Targeting LigandsPeptide-mediated Brain TargetingTargeted Delivery Across The Blood-brain Barrier
Abstract Lysosomes of brain capillary endothelial cells are implicated in nicotine acetylcholine receptor (nAChR)‐mediated transcytosis and act as an enzymatic barrier for the transport of peptide ligands to the brain. A D ‐peptide ligand of nAChRs (termed D CDX), which binds to nAChRs with an IC 50 value of 84.5 n M , was developed by retro–inverso isomerization. D CDX displayed exceptional stability in lysosomal homogenate and serum, and demonstrated significantly higher transcytosis efficiency in an in vitro blood–brain barrier monolayer compared with the parent L ‐peptide. When modified on liposomal surface, D CDX facilitated significant brain‐targeted delivery of liposomes. As a result, brain‐targeted delivery of D CDX modified liposomes enhanced therapeutic efficiency of encapsulated doxorubicin for glioblastoma. This study illustrates the importance of ligand stability in nAChRs‐mediated transcytosis, and paves the way for developing stable brain‐targeted entities.
23
Drug Delivery Systems: Entering the Mainstream
Theresa M. Allen, Pieter R. Cullis · Science · 2004 · 4.5K citations
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar, Haoquan Wu, Jodi L. McBride et al. · Nature · 2007 · 1.2K citations